Niagen Bioscience, Inc. (NAGE) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $129.42M | +29.9% |
| 2024 | $99.60M | +19.2% |
| 2023 | $83.57M | +16.0% |
| 2022 | $72.05M | +6.8% |
| 2021 | $67.45M | +13.8% |
| 2020 | $59.26M | +28.0% |
| 2019 | $46.29M | +46.7% |
| 2018 | $31.56M | +48.8% |
| 2017 | $21.20M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $129.42M | +29.9% |
| 2024 | $99.60M | +19.2% |
| 2023 | $83.57M | +16.0% |
| 2022 | $72.05M | +6.8% |
| 2021 | $67.45M | +13.8% |
| 2020 | $59.26M | +28.0% |
| 2019 | $46.29M | +46.7% |
| 2018 | $31.56M | +48.8% |
| 2017 | $21.20M | — |